ArticlePeerJ2026
Development and validation of a model for early prediction of severe/critical COVID-19 in elderly patients.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The mortality rate of severe/critical coronavirus disease (COVID-19) is high in the elderly, and early prediction of its prognosis can facilitate timely treatment and reduce mortality. This study aims to identify early predictors of severe COVID-19 in elderly and construct a validated risk prediction model. Methods: This retrospective study included 722 elderly COVID-19 patients (those aged ≥60) who attended Nanfang Hospital of Southern Medical University between July 2022 and November 2023. They were categorized as mild/moderate or severe/critical according to the extent of their condition during hospitalization. Predictive models were constructed using logistic regression analysis and visualized using nomograms. Receiver operating characteristic (ROC) curves were used to assess the model's accuracy and predictive value. An external validation cohort containing 1,249 elderly COVID-19 patients who were admitted to Huashan Hospital of Fudan University between March and May 2022 was also collected. Results: In multivariable logistic regression analysis, respiratory rate, comorbid diabetes, C-reactive protein (CRP), lymphocyte percentage, and D-dimer were independently associated with severe and critical COVID-19. Based on these findings, the final severity prediction model was constructed using three laboratory markers: CRP, lymphocyte percentage, and D-dimer. This model achieved an area under the curve (AUC) of 0.753 (0.713-0.794). For mortality prediction, CRP and D-dimer emerged as the significant independent predictors; the model showed an AUC of 0.722 (0.653-0.791) in the internal validation cohort and 0.877 (0.833-0.921) in the external validation cohort. Conclusions: The predictive model incorporating features selected
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.